Meaning: Biocompatibility

Meaning: Biocompatibility

Biocompatibility refers to a material’s ability to be well tolerated by the human body without triggering any undesirable local or systemic reactions. A biocompatible material fulfils its intended function – for example, as a filler or implant – without causing harmful effects such as inflammation, allergies or toxic damage. It is therefore gentle on the body.

The Meaning The importance of biocompatibility cannot be overstated. It forms the basis for safe aesthetic treatments. Non-biocompatible materials can lead to complications ranging from mild skin irritation to serious health problems. It is therefore essential to carefully assess and select biocompatible materials for products such as dermal fillers, breast implants or pigments for permanent make-up, in order to minimise risks and strengthen confidence in the treatment.

Biocompatibility testing in accordance with ISO 10993

Biocompatibility testing is a strictly standardised process, governed internationally primarily by the series of standards ISO 10993 („Biological evaluation of medical devices“) is regulated. This standard specifies which tests are required for which products and materials.

The testing process typically involves:

1. Material characterisation: Detailed analysis of the chemical composition.
2. Risk analysis: Assessment of potential biological hazards.
3. Test selection and administration:
   • In vitro tests (Laboratory tests on cell cultures, e.g. to assess cytotoxicity) are given priority in order to avoid animal testing.
   • In vivo tests (Animal testing) is only carried out if other methods do not allow for an adequate safety assessment (e.g. for sensitisation or complex implantation reactions). The 3R principle (Replace, Reduce, Refine) is the guiding principle here.
   • Chemical analyses (e.g. leachable substances).
4. Overall rating: All the results are incorporated into a final safety assessment.

Important: ISO 10993 provides a framework. The specific tests are tailored to the product and its intended use in order to ensure safety on a sound scientific basis.

Risks associated with the use of materials with inadequate biocompatibility

Although many materials used in aesthetic medicine are generally considered safe, as with any treatment, there are certain Risks. Possible complications include:

• Infections at the puncture or injection sites
• Loss of adipose tissue, when fat cells do not receive sufficient blood flow and die off
• Thrombosis or embolism, particularly where the equipment is not used correctly
• Seroma (fluid build-up) or haematomas
• Asymmetrical results or uneven fat distribution
• Scarring at the collection points

Choosing an experienced plastic surgeon, undergoing a thorough pre-operative examination and following all aftercare instructions are crucial for a good outcome and a recovery with as few complications as possible.

Biocompatible materials in aesthetic medicine

Many materials that have a proven track record in aesthetic medicine are considered to be highly biocompatible:

• Hyaluronic acid: A synthetically produced substance identical to that found in the body, frequently used in dermal fillers.
• Polylactic acid (PLA) & polycaprolactone (PCL): Biodegradable polymers in absorbable sutures and some fillers.
• Silicones (medical grade): For breast implants and other long-term implants.
• Titanium: For dental implants and permanent surgical implants.
• Specifically tested pigments: For permanent make-up, which is subject to strict purity requirements.

Although the product is generally well tolerated, individual reactions cannot be entirely ruled out in rare cases.

Insure against consequential costs

Risks associated with a lack of biocompatibility

If materials are used that are not sufficiently biocompatible, a range of undesirable reactions may occur. These range from:

• Localised inflammation, redness, swelling and pain
• Persistent itching or a burning sensation
• Allergic reactions, ranging from a rash to severe systemic reactions
• Formation of nodules (granulomas) or excessive scarring
• Reactions of rejection to implants
• Release of toxic substances with the potential to cause long-term damage

These complications can not only be a burden on one’s health, but also cause considerable Follow-up costs for any necessary follow-up treatment, corrections or the removal of the material. Particularly in the case of cosmetic procedures, which are often not covered by standard health insurance schemes, these additional costs can represent a considerable financial burden.